1-3 of 3
Helle Toldbod, MS,PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

Francesco d'Amore, MD, Sirpa Leppä, MD, Maria Gomes da Silva, MD PhD, Thomas Relander, Grete Fossum Lauritzsen, Peter De Nully Brown, Antonio Pezzutto, Jeanette K. Doorduijn, MD PhD, Eckhart Weidmann, Michel van Gelder, Achiel Van Hoof, Ilse Christiansen, Unn Merete Fagerli, MD PhD, Hans Hagberg, MD, P.J. Lugtenburg, Jan Walewski, Ka Lung Wu, Hilde Maria Demuynck, Rob Fijnheer, Jacob H. Christensen, Milada Jankovská, MD, Pär L. Josefsson, Hanneke Kluin-Nelemans, Jose Mario Mariz, MD, Mats A. Merup, Thomas Noesslinger, Eric Van Den Neste, Josée M Zijlstra, MD, Georg Hopfinger, MD, VIT Prochazka, MD, Esa Jantunen, MD PhD, Ludmila Boudova, Jose Cabecadas, Andreas Chott, Jan M.A. Delabie, MD PhD, Laurence de Leval, MD, Arjan Diepstra, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Peter Noergaard, Andreas Rosenwald, Grzegorz Rymkiewicz, Christer Sundström, Lorenz Truemper, MD, Gerald Wulf, MD, Lauren Chong, MSc, Alyssa Bouska, PhD, Lynette Smith, Christian Gisselbrecht, Marita Ziepert, PhD, Markus Loeffler, MD, Knut Liestol, Christian Steidl, MD, Randy D. Gascoyne, MD, David W. Scott, PhDMD,FRACP,FRCPA, Bettina Altmann, PhD, Javeed Iqbal, §, Wing C Chan, MD, Helle Toldbod, MS,PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 998.
https://doi.org/10.1182/blood-2018-99-110429
Published: 2018
Journal Articles

Alemtuzumab Added to CHOP for Treatment of Peripheral T-Cell Lymphoma (PTCL) in Previously Untreated Young and Elderly Patients: Pooled Analysis of the International ACT-1/2 Phase III Trials

Bettina Altmann, PhD, Gerald Wulf, MD, Lorenz Truemper, MD, Francesco d'Amore, MD, Thomas Relander, Helle Toldbod, MS,PhD, Jan M.A. Delabie, MD PhD, Andreas Rosenwald, Marita Ziepert, PhD, Markus Loeffler, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1622.
https://doi.org/10.1182/blood-2018-99-112076
Published: 2018
Journal Articles

The Impact of Upfront Autologous Transplant on the Survival of Adult Patients with ALCL and PTCL-NOS According to Their ALK , DUSP22 and TP63 Gene Rearrangement Status - a Joined Nordic Lymphoma Group and Mayo Clinic Analysis

Martin Bjerregård Pedersen, MD PhD, Thomas Relander, MD PhD, Grete Fossum Lauritzsen, PhD MD, Fredrik Ellin, MD MSc, Sirpa Leppä, MD PhD, Susanna Mannisto, MD PhD, Esa Jantunen, MD, Rhett P. Ketterling, MD, Patrick Bedroske, BS, Ivy Luoma, BA, Christopher Sattler, BS, Jan M.A. Delabie, MD PhD, Christer Sundstrom, MD, Birgitta Sander, MD PhD, Marja-Liisa Karjalainen-Lindsberg, Stephen Hamilton-Dutoit, MD, Mats Ehinger, MD PhD, M Vornanen, MD, Elisabeth Ralfkiaer, MD DMSC, Rebecca Boddicker, PhD, Nabila Nora Bennani, MD, Naoki Oishi, MD PhD, Michael Boe Moeller, Peter Noergaard, MD, James R. Cerhan, MD PhD, Matthew J Maurer, MS, Knut Liestol, Helle Toldbod, MS,PhD, Andrew L Feldman, MD, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 822.
https://doi.org/10.1182/blood.V130.Suppl_1.822.822
Published: 2017